Eight-year survival after advanced gastric cancer treated with S-1 followed by surgery

World Journal of Gastroenterology

Volumn 16, Issue 22, 2010, Pages 2824-2827

  Hijioka, Susumu ^a   Chin, Keisho ^a   Seto, Yasuyuki ^a   Yamamoto, Noriko ^a   Hatake, Kiyohiko ^a  

^a CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

Gastrectomy; Gastric cancer; Lymph node metastasis; S 1

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC AGENT S1; UNCLASSIFIED DRUG;

ABDOMINAL DISCOMFORT; ABDOMINAL PARAAORTIC LYMPH NODE METASTASIS; ADVANCED CANCER; AGED; ARTICLE; AXILLARY LYMPH NODE METASTASIS; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CASE REPORT; CERVICAL METASTASIS; COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPY; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; SIGNET RING CARCINOMA; STOMACH ADENOCARCINOMA; STOMACH BIOPSY; STOMACH CANCER; STOMACH ULCER;

EID: 77954264942     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i22.2824     Document Type: Article

References (15)

1. Hallissey MT, Dunn JA, Ward LC, Allum WH. The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five-year follow-up. Lancet 1994; 343: 1309-1312
2. Japanese Gastric Cancer Assosiation. Japanese classification of gastric carcinoma, second English edition. Gastric Cancer 1998; 1: 20-24
3. Foukakis T, Lundell L, Gubanski M, Lind PA. Advances in the treatment of patients with gastric adenocarcinoma. Acta Oncol 2007; 46: 277-285
4. Boku N, Yamamoto S, Fukuda H, Shirao K, Doi T, Sawaki A, Koizumi W, Saito H, Yamaguchi K, Takiuchi H, Nasu J, Ohtsu A. Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study. Lancet Oncol 2009; 10: 1063-1069
5. Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M, Miyashita K, Nishizaki T, Kobayashi O, Takiyama W, Toh Y, Nagaie T, Takagi S, Yamamura Y, Yanaoka K, Orita H, Takeuchi M. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol 2008; 9: 215-221
6. Ohtsu A, Shimada Y, Shirao K, Boku N, Hyodo I, Saito H, Yamamichi N, Miyata Y, Ikeda N, Yamamoto S, Fukuda H, Yoshida S. Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205). J Clin Oncol 2003; 21: 54-59
7. Van Cutsem E, Moiseyenko VM, Tjulandin S, Majlis A, Constenla M, Boni C, Rodrigues A, Fodor M, Chao Y, Voznyi E, Risse ML, Ajani JA. Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group. J Clin Oncol 2006; 24: 4991-4997
8. Al-Batran SE, Hartmann JT, Probst S, Schmalenberg H, Hollerbach S, Hofheinz R, Rethwisch V, Seipelt G, Homann N, Wilhelm G, Schuch G, Stoehlmacher J, Derigs HG, Hegewisch-Becker S, Grossmann J, Pauligk C, Atmaca A, Bokemeyer C, Knuth A, Jäger E. Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie. J Clin Oncol 2008; 26: 1435-1442
9. Yoshida M, Ohtsu A, Boku N, Miyata Y, Shirao K, Shimada Y, Hyodo I, Koizumi W, Kurihara M, Yoshida S, Yamamoto S. Long-term survival and prognostic factors in patients with metastatic gastric cancers treated with chemotherapy in the Japan Clinical Oncology Group (JCOG) study. Jpn J Clin Oncol 2004; 34: 654-659
10. Ohyama S, Komatsu O, Nakajima T, Ohta K, Takahashi T, Yanagisawa A. A case report of pathological complete remission with FLEP therapy. In: Nakajima T, Yamaguchi T, editors. Multimodality therapy for gastric cancer. Berling, Heideberg New York Tokyo: Springer-Verlag, 1999: 104-107
11. Iwazawa T, Kinuta M, Yano H, Matsui S, Tamagaki S, Yasue A, Okada K, Kanoh T, Tono T, Nakano Y, Okamoto S, Monden T. An oral anticancer drug, TS-1, enabled a patient with advanced gastric cancer with Virchow's metastasis to receive curative resection. Gastric Cancer 2002; 5: 96-101
12. Kajihara K, Ishikawa H, Akama F, Ninomiya H, Shigeta K, Sano I, Nakamura Y, Iwasaki K. [A case of advanced gastric cancer with virchow's metastasis responding remarkably to combination chemotherapy of low-dose CDDP and 5-FU] Gan To Kagaku Ryoho 1998; 25: 585-588
13. Wada Y, Kamiya N, Asano S, Shinya F. [A case of advanced gastric cancer with Virchow's and paraaortic lymph node metastases successfully resected after combined chemotherapy of low-dose CDDP and 5-FU] Gan To Kagaku Ryoho 2001; 28: 79-82
14. Umehara Y, Okubo T, Sano Y, Sakamoto R, Nakamura T, Tsuchiya Y, Nagato Y, Moriyama R. [A case of advanced gastric remnant carcinoma with Virchow's metastasis treated with neoadjuvant chemotherapy (low dose CDDP + 5-FU) followed by surgical resection] Gan To Kagaku Ryoho 1995; 22: 277-279
15. Japanese Gastric Cancer Association. Gastric cancer treatment guideline (in Japanese). Tokyo: Kanehara, 2004: 22-38